Raltegravir
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2247 publications
Evolution and emergence of the integrase inhibitor 231 insertion resistance mutation in an HIV-2 strain isolated in central Portugal.
Journal: Virus genes
Published: February 16, 2026
Safety and Tolerability of Raltegravir in a Premature Neonate: A Case Report.
Journal: The Pediatric infectious disease journal
Published: January 28, 2026
An In Silico and In Vitro Approach Identified Potential Trypanothione Synthetase Inhibitors with Trypanocidal Activity.
Journal: Molecules (Basel, Switzerland)
Published: January 27, 2026
Real-Life Long-Term Weight Trends After Switching to INSTI-Based Therapy in People Living with HIV: A 12-Year Retrospective Cohort Study.
Journal: The new microbiologica
Published: December 23, 2025
Efavirenz-Induced Hepatitis Mimicking Autoimmune Hepatitis: A Case Report.
Journal: Cureus
Published: December 18, 2025
Deep sequencing reveals underestimated burden of integrase inhibitor resistance mutations in people living with HIV: a global individual patient data meta-analysis.
Journal: Emerging microbes & infections
Published: November 26, 2025
Association between plasma concentrations of integrase strand transfer inhibitors and body weight gain in women living with HIV.
Journal: AIDS (London, England)
Published: November 06, 2025
Antiretroviral Raltegravir, a Selective Human Immunodeficiency Virus Type 1 Integrase Inhibitor, Shows Anti-Alzheimer's Potential against Amyloid-Beta1-42-Induced Neurodegeneration.
Journal: Mechanisms of ageing and development
Published: October 29, 2025
Pharmacovigilance study of INSTIs associated with weight gain and glucose/lipid metabolism adverse events based on the FDA adverse event reporting system.
Journal: HIV medicine
Published: October 11, 2025
A 48-week, Randomized Controlled Trial of Doravirine for Individuals with HIV and Obesity on Integrase Inhibitors and Tenofovir Alafenamide: The Do IT Study (ACTG A5391).
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: October 07, 2025
Post-Exposure Prophylaxis: For Sexual Exposure in the LGBTQIA+ Community.
Journal: Advanced emergency nursing journal
Published: September 08, 2025
Prioritization of adverse events related to integrase inhibitors and NNRTIs: a disproportionality analysis using data from the FAERS database.
Journal: The Journal of antimicrobial chemotherapy
Published: August 28, 2025
Last Updated: 04/28/2026